期刊文献+

美罗培南治疗神经外科手术后颅内感染病例分析

原文传递
导出
摘要 目的探究美罗培南治疗神经外科手术后颅内感染病例分析。方法选自2017年1月至2018年1月收取的60例颅内感染患者作为分析,依照抛硬币的形式分成两组各30例,两组分别采取不同的给药方式,甲组是美罗培南微量泵,乙组为静脉滴注。细化分为乙组是常规静脉滴注,甲组是持续静脉输注。比较两组患者治疗效果和用药时长、体温恢复时间以及住院时间。结果甲组的治疗效果与乙组基本相同,数据差异并没有显著的改变;观察组患者的用药时长、体温恢复时间以及住院时间等优于乙组,数据差异有变化。结论对于神经外科手术后出现颅内感染应该采取微量泵持续输注美罗培南药物,可以帮助患者提升治疗效果,降低住院时间。此外,临床应该大力的宣传并且推广。
出处 《灾害医学与救援(电子版)》 2018年第2期98-98,共1页 Disaster Medicine and Rescue(Electronic Edition)
  • 相关文献

参考文献3

二级参考文献24

  • 1周建新,王强,唐明忠,赵继宗.神经外科患者脑脊液细菌流行病学和耐药性监测[J].中华医院感染学杂志,2006,16(2):154-157. 被引量:52
  • 2Sunagawa M, Matsumura H, Smita Y, et al.Structural features resulting in convulsive activity of carbapenem compounds:effect of C-2 side chain. J Antibiot,1995,48:408-416.
  • 3Hartenauer U, Kljucar S, Bender HJ, et al. Meropenem versus imipenem/ cilastatin for the treatment of serious bacterial infections in the ICU. Anti-infective Drugs Chemother,1997,15:65-70.
  • 4Colardyn F, Faulkner KL. Meropenem serious infection study group. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. J Antimicrob Chemother,1996,38:523-537.
  • 5Linden P. Safety profile of meropenem : an updated review of over 6000 patients treated with meropenem. Drug Saf,2007,30: 657-668.
  • 6Fabian TC, File TM, Embil JM, et al. Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study. Surg Infect (Larchmt),2005, 6:269-282.
  • 7Verwaest C. Meropenem versus imipenem/eilastatin as empiric monotherapy for serious bacterial infections in the intensive care unit. Clin Microbiol Infect,2000,6:294-302.
  • 8Koppel BS, Hauser WA, Politis C, et al. Seizures in the Critically Ⅲ: The Role of Imipenem. Epilepsia,2001,42:1590-1593.
  • 9Bartoloni A, Strohmeyer M, Corti G, et al. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.Drugs Exp Clin Res,1999,25:243-252.
  • 10Hou F, Li J, Wu G, et al. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections. Chin Med J,2002, 115:1849-1854.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部